CRF Health Appoints Chief Operating Officer
News Sep 20, 2016
CRF Health, the leading global provider of eCOA solutions for the life sciences industry, announces the appointment of Jamie Moss as Chief Operating Officer (COO), assuming responsiblility for CRF Health’s global operations. The company has enjoyed significant growth and continued investment in the eCOA space having recently acquired mHealth provider, Entra Health. This appointment continues to place an emphasis on ensuring quality and scalable operational delivery to meet growing customer demand.
With more than 26 years’ experience in business critical operational, manufacturing and senior executive roles across the aerospace, engineering, professional services and energy sectors, Moss comes to the organization with a strong belief in Lean Six Sigma and a drive for growth acceleration, process improvement and quality. Most recently he was Head of Engineering Capability for QinetiQ’s Air Division. Prior to that Moss was COO for Lockheed Martin Commercial Flight Training and has also held diverse roles at Rolls-Royce, including Managing Director of the organization’s Aero Repair & Overhaul business.
Discussing the appointment, CRF Health’s CEO, Rachael Wyllie, said: “I am pleased to announce Jamie Moss as CRF Health’s new COO. His track record in process enhancement and building cultures of improvement will be a tremendous asset to us as we expand our business in an industry that is increasingly looking to eCOA as a key tool in optimizing its drug research programs.”
Jamie Moss, stated: “I am delighted to join CRF Health at such an exciting point in its development. With a strategy focused on quality and innovation, and investment in the company’s team a priority, I look forward to helping to drive the next phase in CRF Health’s growth.”
For further information on CRF Health, please visit www.crfhealth.com.
About CRF Health
CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 800 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019